IP Library › Granted Patent US 11,123,308
Granted Patent B2
US 11,123,308 · App. 16/646,533 · Granted Sep 21, 2021

Composition containing cannabidiol and/or cannabidivarol and application thereof in treatment of dysmenorrhea

Inventors: Zhaohui Yu (Beijing, CN); Ke Zhang (Beijing, CN); Xin Tan (Beijing, CN)
Assignee: HANYI BIO-TECHNOLOGY (BEIJING) CO., LTD.
A61K31/05A61F13/472A61K9/7023A61L15/20A61L15/44A61P15/00A61F2013/4708A61L2300/216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,308
App. No.
16/646,533
Granted
Sep 21, 2021
Kind
B2
Abstract

The present invention discloses a composition for preventing and/or treating woman dysmenorrhea; the composition includes cannabidiol and/or cannabidivarol, a penetration enhancer as well as a carrier; the mass ratio of the cannabidiol and/or the cannabidivarol to the penetration enhancer is 1:(0.1-0.8). The composition provided by the present invention can effectively relieve woman dysmenorrhea, and solve the problem of lackness of a composition of cannabidiol and/or cannabidivarol which can effectively prevent and/or treat woman dysmenorrhea in the prior art. Meanwhile, the composition provided by the present invention can also be used in preparation of a feminine hygiene product for preventing and/or treating woman dysmenorrhea.

Claims (14)

1. A feminine hygiene product comprising a composition for treating dysmenorrhea, wherein the composition comprises cannabidiol and cannabidivarol, a penetration enhancer and a carrier, wherein a mass ratio of cannabidiol to cannabidivarol is (0.1-10):1.

2. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 , wherein the penetration enhancer is azone.

3. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 , wherein the mass ratio of the cannabidiol and/or cannabidivarol to the penetration enhancer is 1:(0.1-0.8).

4. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 , wherein the cannabidiol and cannabidivarol is extracted from a hemp plant, and the extraction site of the hemp plant is one or a combination of any two and more of hemp seeds, hemp leaves, hemp flowers, hemp stalk cores, and hemp roots at any ratio.

5. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 , wherein the composition is in a form of liquid, gel, ointment or patch.

6. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 ,

wherein the carrier is one or a combination of two or more selected from yarns, cotton threads or hemp fiber.

7. The feminine hygiene product comprising the composition for treating dysmenorrhea according to claim 1 , wherein the carrier also contains one or a combination of two or more of a binder, a filler, a humectant, a crosslinking agent, a coloring agent, a pH regulator, and a preservative.

8. The feminine hygiene product comprising the composition for treating dysmenorrheal according to claim 7 , wherein the binder is one or any combination of two or more selected from gelatin, sodium alginate, gum arabic, starch, methyl cellulose, carboxymethyl cellulose and its sodium salt, polyvinyl alcohol, polyethylene glycol, polyvinylpyrrolidone, carbomer, and polyacrylic acid and its sodium salt; the filler is one or any combination of two or more selected from zinc oxide, colloidal silicon dioxide, calcium carbonate, diatomaceous earth, and titanium dioxide; the humectant is any one or a combination of two or more selected from glycerol, propylene glycol, sorbitol, and polyethylene glycol; and the crosslinking agent is any one or a combination of two or more selected from calcium hydroxide, aluminum trichloride, aluminum glycinate, and EDTA disodium.

9. The feminine hygiene product comprising the composition for treating dysmenorrheal according to claim 1 , wherein the mass ratio of the cannabidiol and/or cannabidivarol to the carrier in the composition is 1:(4-50).

10. The feminine hygiene product according to claim 1 , wherein the feminine hygiene product is a sanitary towel, a sanitary napkin or a panty liner.

11. A method for treating dysmenorrhea using a feminine hygiene product for treating dysmenorrhea, wherein the method comprises applying a composition comprising cannabidiol and cannabidivarol, a penetration enhancer and a carrier, wherein a mass ratio of cannabidiol to cannabidivarol is (0.1-10):1, and a carrier comprising one or more of yarns, cotton threads or hemp fiber.

12. The method for treating dysmenorrhea using a feminine hygiene product according to claim 11 , wherein the the mass ratio of the cannabidiol to the cannabidivarol is (0.1-10):1.

13. The method for treating dysmenorrheal using a feminine hygiene product according to claim 11 , wherein the mass ratio of the cannabidiol and cannabidivarol to the penetration enhancer is 1:(0.1-0.8).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: YU, ZHAOHUI; ZHANG, KE; TAN, XIN
To: HANYI BIO-TECHNOLOGY COMPANY LTD.
Reel/Frame 052151/0511 →
Priority Claims (1)
CN 201710835129.8 · Sep 15, 2017 · national
Continuity (1)
Related Publication 20200261376A1 · Aug 20, 2020
Cited By (5)
US 12,251,411 US 12,318,399 US 12,409,199 US 12,440,528 US 12,599,617